06 July,2024 10:01 AM IST | Mumbai | IANS
Image for representational purposes only. Photo Courtesy: iStock
An international team of researchers from the UK and China has shown how cancer builds up resistance to chemotherapy -- one of the biggest challenges in the treatment of the deadly disease.
Using a mice study, the early-stage research, led by The Institute of Cancer Research (ICR), London, and Sun Yat-sen University, China showed that Stiripentol -- a drug currently used to treat epilepsy -- can help reverse cancer's resistance to chemotherapy, which will help shrink tumours and prolong survival.
In the study, the team zeroed in on lactate -- the product that builds up as cancer cells convert nutrients to energy -- which was found to be most abundant in chemotherapy-resistant cancer tissues.
For the study, published in the journal Nature, the researchers examined tissue from 24 patients with stomach cancer, where 15 of the cancers were resistant to chemotherapy and the tumours had continued to grow.
ALSO READ
Mumbai: Doctors save 69-year-old Vasaikar’s life with high-risk heart surgery
Odisha: Doctors save life of Army jawan whose heart stopped beating for 1.5 hrs
Struggle to keep morning routines? Listen to this podcast and laugh about it
Say goodbye to chapped lips: Your ultimate winter lip care guide
IIT-M study finds oral contraceptives do not raise BP in women during workout
Stiripentol and chemotherapy reduced the size of tumours -- for four weeks after treatment -- in mice with stomach cancer. These also survived for longer -- for more than 70 days.
In comparison, tumours in mice treated with chemotherapy alone shrunk for one week and started to grow again. With only chemotherapy, no mice survived for longer than 40 days after treatment.
Further, lactate was also found responsible for altering the structure of a key protein involved in DNA repair, called NBS1, and affecting its efficiency.
The researchers believe that lactate may be behind chemotherapy resistance in other cancers such as "pancreatic, lung and ovarian cancers".
"This extremely promising research has uncovered a likely mechanism for how cancer evades chemotherapy," said Professor Axel Behrens, Professor of Stem Cell Biology at The Institute of Cancer Research.
"In our early-stage study, we've seen that you can prevent the build-up of lactate and make a tumour that was resistant to chemotherapy sensitive again -- the treatment continues to work," Axel added.
Also read: Karnataka govt asks DCs to be vigilant against Zika virus spread along with dengue
